Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 1:57 pm Sale |
2024-09-30 | 13G | ZoomInfo Technologies Inc. ZI |
Wellington Management Group LLP | 1,730,961 0.470% |
-24,063,575 (-93.29%) |
Filing History |
| 2024-11-08 1:56 pm Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
Wellington Management Group LLP | 7,030,949 5.970% |
7,030,949 (New Position) |
Filing History |
| 2024-11-08 1:47 pm Sale |
2024-09-30 | 13G | Flex Ltd. FLEX |
Wellington Management Group LLP | 34,365,862 8.650% |
-6,347,559 (-15.59%) |
Filing History |
| 2024-11-08 1:46 pm Purchase |
2024-09-30 | 13G | Antero Resources Corporation AR |
Wellington Management Group LLP | 17,459,283 5.610% |
17,459,283 (New Position) |
Filing History |
| 2024-11-08 10:54 am Purchase |
2024-09-30 | 13G | Hamilton Insurance Group, Ltd. HG |
Wellington Management Group LLP | 3,715,579 6.060% |
3,715,579 (New Position) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
Wellington Management Group LLP | 23,309,313 13.950% |
10,192,335 (+77.70%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Acadia Healthcare Company, Inc. ACHC |
Wellington Management Group LLP | 11,658,253 12.550% |
1,420,161 (+13.87%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | agilon health, inc. AGL |
Wellington Management Group LLP | 52,882,595 12.850% |
10,372,565 (+24.40%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
Wellington Management Group LLP | 7,896,632 11.370% |
867,008 (+12.33%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
Wellington Management Group LLP | 23,964,044 8.080% |
8,774,020 (+57.76%) |
Filing History |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Wellington Management Group LLP | 15,599,529 12.810% |
-878,321 (-5.33%) |
Filing History |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | The AZEK Company Inc. AZEK |
Wellington Management Group LLP | 14,224,410 9.830% |
-694,216 (-4.65%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX |
Wellington Management Group LLP | 9,243,599 13.940% |
2,767,038 (+42.72%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Wellington Management Group LLP | 4,459,691 5.570% |
1,214,586 (+37.43%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Denali Therapeutics Inc. DNLI |
Wellington Management Group LLP | 10,727,450 7.490% |
3,452,733 (+47.46%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | EQT Corporation EQT |
Wellington Management Group LLP | 74,153,050 12.480% |
29,447,572 (+65.87%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Exact Sciences Corporation EXAS |
Wellington Management Group LLP | 14,652,858 7.930% |
4,116,099 (+39.06%) |
Filing History |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | Exelon Corporation EXC |
Wellington Management Group LLP | 65,026,846 6.500% |
-28,119,223 (-30.19%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Hannon Armstrong Sustainable Infrastructure Capital, Inc. HASI |
Wellington Management Group LLP | 13,487,986 11.550% |
2,024,555 (+17.66%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX |
Wellington Management Group LLP | 2,937,853 9.220% |
2,937,853 (New Position) |
Filing History |